论文信息 - NPM mutations in acute myelogenous leukemia. - 字舞流文

NPM mutations in acute myelogenous leukemia.

Nucleophosmin (NPM) is a multifunctional phosphoprotein to which both tumor-suppressor and oncogenic functions have been attributed. Chromosomal translocations involving the NPM1 gene occur not inf...

Pier Paolo Pandolfi | P. Pandolfi | Silvia Grisendi | S. Grisendi

[1] Charles J. Sherr,et al. Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23 , 2004, Molecular and Cellular Biology.

[2] S. Corey,et al. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. , 1996, Blood.

[3] D N Shapiro,et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.

[4] T. Taniguchi,et al. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity , 1997, Oncogene.

[5] Pier Giuseppe Pelicci,et al. Nucleophosmin regulates the stability and transcriptional activity of p53 , 2002, Nature Cell Biology.

[6] P. Pandolfi,et al. Does the ribosome translate cancer? , 2003, Nature Reviews Cancer.

[7] H. F. Horn,et al. Nucleophosmin/B23 Is a Target of CDK2/Cyclin E in Centrosome Duplication , 2000, Cell.

[8] S. Raimondi,et al. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. , 1996, Oncogene.

[9] Paola Fazi,et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. , 2005, The New England journal of medicine.